Concomitant TTFields with Sorafenib Enhances Treatment Efficacy in Vivo: “Tumor histology and immunostaining for beclin-1 and LC3, GRP78, and cleaved PARP were performed to examine autophagy, ER stress, and apoptosis levels, respectively.
Moreover, there is a discrepancy between the fold changes in tumor weight vs. volume in the combination group vs. untreated group.